Skip to main content
. Author manuscript; available in PMC: 2015 Jul 29.
Published in final edited form as: J Card Fail. 2007 Sep;13(7):588–596. doi: 10.1016/j.cardfail.2007.04.009

Fig. 4.

Fig. 4

Effect of kallikrein and kinin on (A) cardiac NO levels, (B) NADPH oxidase activity, (C) p22phox mRNA levels, (D) MDA in the non-infarct myocardium and (E) superoxide formation. Data are expressed as mean ± SEM (n=6-7).